There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The quadrivalent human papillomavirus virus vaccine was recently licensed for use
in males in the United States. This study reviews available published literature on
acceptability among parents, health care providers, and young males. Among 23 published
articles, half were conducted in the United States. The majority (87%) used quantitative
survey methodology, and 13% used more explorative qualitative techniques. Convenience
samples were used in most cases (74%) and 26% relied on nationally representative
samples. Acceptability of a human papillomavirus virus (HPV) vaccine that protects
against cervical cancer and genital warts was high in studies conducted among male
college students (74%-78%) but lower in a community sample of males (33%). Among mothers
of sons, support of HPV vaccination varied widely from 12% to 100%, depending on the
mother's ethnicity and type of vaccine, but was generally high for a vaccine that
would protect against both genital warts and cervical cancer. Health providers' intention
to recommend HPV vaccine to male patients varied by patient age but was high (82%-92%)
for older adolescent patients. A preference to vaccinate females over males was reported
in a majority of studies among parents and health care providers. Messages about cervical
cancer prevention for female partners did not resonate among adult males or parents.
Future acceptability studies might incorporate more recent data on HPV-related disease,
HPV vaccines, and cost-effectiveness data to provide more current information on vaccine
acceptability.
Published by Elsevier Inc.